| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/04/2003 | CA2476999A1 Sterile immunogenic non-tumorigenic tumor cell compositions and methods |
| 09/04/2003 | CA2476994A1 Methods of extending corneal graft survival |
| 09/04/2003 | CA2476887A1 Gasp1:a follistatin domain containing protein |
| 09/04/2003 | CA2476776A1 Reagents and treatment methods for autoimmune diseases |
| 09/04/2003 | CA2476666A1 Haemophilus adherence and penetration proteins |
| 09/04/2003 | CA2476571A1 Method for isolating ligands |
| 09/04/2003 | CA2476518A1 Compositions and methods for the treatment of immune related diseases |
| 09/04/2003 | CA2475774A1 Monoclonal antibodies that are cross-reactive against bacterial collagen binding proteins |
| 09/04/2003 | CA2475526A1 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 09/04/2003 | CA2475509A1 Treatment methods using anti-cd22 antibodies |
| 09/04/2003 | CA2475039A1 Macromolecular conjugates and processes for preparing same |
| 09/04/2003 | CA2471307A1 Protein complexes and methods for their use |
| 09/04/2003 | CA2467833A1 Pharmaceutical compositions in particulate form |
| 09/03/2003 | EP1340815A2 Determination of alpha-N-acetylgalactosaminidase activity |
| 09/03/2003 | EP1340811A2 Antibodies with specificity for multiple adhesion molecules |
| 09/03/2003 | EP1340769A1 CD4-gamma2 and CD4-IgG2 chimeras |
| 09/03/2003 | EP1340493A1 Solid support for extemporaneous homeopathic medicine |
| 09/03/2003 | EP1340088A2 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 09/03/2003 | EP1340086A1 Assay for directly detecting a rs virus related biological cell in a body fluid sample |
| 09/03/2003 | EP1340079A2 S. aureus protein staau-r2, gene encoding it and uses thereof |
| 09/03/2003 | EP1339871A1 Diagnosis and treatment of tumor-suppressor associated disorders |
| 09/03/2003 | EP1339847A2 Transforming growth factor-beta-related molecules and uses thereof |
| 09/03/2003 | EP1339846A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/03/2003 | EP1339833A1 Dehydrated antigen presenting cells usable for vaccination |
| 09/03/2003 | EP1339738A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/03/2003 | EP1339708A2 Indole-type inhibitors of p38 kinase |
| 09/03/2003 | EP1339427A2 Method of producing biospecific molecules by protein trans-splicing |
| 09/03/2003 | EP1339425A2 Vaccine composition containing transforming growth factor alpha |
| 09/03/2003 | EP0914614B1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrPsc |
| 09/03/2003 | EP0857210B1 Therapeutic antiangiogenic compositions and methods |
| 09/03/2003 | EP0841943B1 Avirulent herpetic viruses useful as tumoricidal agents and vaccines |
| 09/03/2003 | EP0833670B1 Vaccine against rotavirus infection comprising peptides of viral enterotoxin nsp4 |
| 09/03/2003 | EP0773030B1 Method of purifying necrotoxin produced by bordetella |
| 09/03/2003 | EP0765172B1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 09/03/2003 | EP0751780B1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 09/03/2003 | EP0684831B1 Allogenic vaccine and method to synthesize same |
| 09/03/2003 | EP0673425B1 Dna encoding chitin deacetylase |
| 09/03/2003 | EP0651646B1 Therapeutic conjugates of toxins and drugs |
| 09/03/2003 | EP0607297B1 Hormone analogs with multiple ctp extensions |
| 09/03/2003 | CN1440462A Method of identifying and producing antigen peptides and use thereof as vaccines |
| 09/03/2003 | CN1440459A Expression system |
| 09/03/2003 | CN1440456A Sentinel virus Ôàí" |
| 09/03/2003 | CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 09/03/2003 | CN1440423A Immunoadhesin for the prevention of rhinovirus infection |
| 09/03/2003 | CN1440419A Compounds and methods for treatment and prevention of bacterial infection |
| 09/03/2003 | CN1440296A Vaccine against foot-and-mouth disease |
| 09/03/2003 | CN1440295A Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol monno-oligosaccharide |
| 09/03/2003 | CN1439651A Recombined human CD11a monoclone antibody and its preparation and medicinal composition |
| 09/03/2003 | CN1439428A Medical use and medicinal preparation of trichonema in preventing human and animals from diseases by immunologic inadequacy |
| 09/03/2003 | CN1439424A Anti-SARS virus transfer factor preparation method |
| 09/03/2003 | CN1120238C Pure herpes virus recombined with visco-particle as basement and its use |
| 09/03/2003 | CN1120166C New class of benzoporphyrin derivative photoactive compounds |
| 09/02/2003 | US6613892 Continuously expressing an inserted heterologous gene while remaining latent |
| 09/02/2003 | US6613891 Polynucleotides that encode bovine inhibin |
| 09/02/2003 | US6613881 Isolated polypeptide of given amino acid sequence; can use in vaccines |
| 09/02/2003 | US6613872 Compounds for immunotherapy of prostate cancer and methods for their use |
| 09/02/2003 | US6613788 Transdermal patch to systemically deliver effective dose of histamine comprising histamine and controlled release preparation which releases drug over period of time sufficient to obtain stable elevated levels in circulating blood |
| 09/02/2003 | US6613753 Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation |
| 09/02/2003 | US6613746 Cell adhesion proteins having cells with glycoprotein antibodies and carbohydrate determinants used to interfere with binding FC receptor and as complement inhibitors; antiinflammatory agents |
| 09/02/2003 | US6613557 Recombinant DNA molecules which encode viral protein; transfecting a host cell with the DNA molecules; used for diagnostic purposes or for incorporation in a vaccine |
| 09/02/2003 | US6613556 Infecting cells from a continuous epithelial or fibroblast cell line, free of contaminants, with a high titer growth strain of dengue virus; use in vaccine production |
| 09/02/2003 | US6613337 Preventing, treating and detecting leishmaniasis and stimulating immune responses in patients. The compounds provided include polypeptides that contain at least an immunogenic portion of one or more Leishmania antigens. |
| 09/02/2003 | US6613336 H.influenzae type b polysaccharide-substantially pure, refolded meningococcal outer membrane protein conjugate; vaccines |
| 09/02/2003 | US6613335 Provided are BASB011 polypeptides and polynucleotides encoding BASB011 polypeptide from Moraxella catarrhalis. Also provided are immunogenic uses. |
| 09/02/2003 | US6613333 Immunodominant human T-cell epitopes of hepatitis C virus |
| 09/02/2003 | US6613332 Oral administration of therapeutic proteins |
| 09/02/2003 | US6613331 Vaccine against Lyme disease |
| 09/02/2003 | US6613330 Methods and compositions for preventing anti-Gal production in xenograft recipients |
| 09/02/2003 | US6613329 Vaccine and antitoxin for treatment and prevention of C. difficile disease |
| 09/02/2003 | US6613328 Methods of treating thrombotic diseases with von Willebrand factor specific antibodies |
| 09/02/2003 | US6613326 Antitoxins and methods for making antitoxins |
| 09/02/2003 | US6613322 Administering enzyme inhibitors |
| 09/02/2003 | US6613321 Strain is unable to express homologous O-polysaccharide due to a 1.2 kb deletion that spans the junction of the rfbA and rfbB genes, and expresses a heterologous O-polysaccharide that is covalently linked to a lipopolysaccharide |
| 09/02/2003 | US6613320 Recombinant CD4+ T cells from an individual afflicted with hyper IgM syndrome transformed with vectors carrying either the wild type or the mutagenized CD40Ls, metabolically radiolabeled, and examined for expression |
| 08/28/2003 | WO2003070987A1 Nucleotide sequence coding for a tolc containing a heterologous amino acid sequence |
| 08/28/2003 | WO2003070981A2 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines |
| 08/28/2003 | WO2003070933A2 Process of cell electrofusion |
| 08/28/2003 | WO2003070920A1 Vaccination and vaccine and drug delivery by topical application of vectors and vector extracts recombinant vectors, and noninvasive genetic immunization, expression products therefrom,and uses thereof |
| 08/28/2003 | WO2003070909A2 Microparticles with adsorbed polypeptide-containing molecules |
| 08/28/2003 | WO2003070890A2 THE p65 SUBUNIT OF NF-κB FOR THE RADIOSENSITIZATION OF CELLS |
| 08/28/2003 | WO2003070883A2 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. |
| 08/28/2003 | WO2003070771A1 Rrp sequences and knockout mice and uses thereof |
| 08/28/2003 | WO2003070767A1 Tissue specific expression |
| 08/28/2003 | WO2003070760A2 Anti-amyloid beta antibodies and their use |
| 08/28/2003 | WO2003070757A1 Nucleic acid encoding an herv-h polypeptide for diagnosing colorectal cancer |
| 08/28/2003 | WO2003070752A2 Mhc-peptide complex binding ligands |
| 08/28/2003 | WO2003070282A2 Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue |
| 08/28/2003 | WO2003070275A1 Use of an inhibitor or antagonist against tissue factor |
| 08/28/2003 | WO2003070272A1 An immunological adjuvant |
| 08/28/2003 | WO2003070271A2 Novel complexes for inducing an immune response |
| 08/28/2003 | WO2003070270A1 Strategy for retroviral immunotherapy |
| 08/28/2003 | WO2003070266A1 Enhanced immunization and suppression of oral tolerance |
| 08/28/2003 | WO2003070256A1 Hyaluronic acid mediated adenoviral transduction |
| 08/28/2003 | WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 08/28/2003 | WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof |
| 08/28/2003 | WO2003070187A2 Fusion proteins of mycobacterium tuberculosis |
| 08/28/2003 | WO2003070164A2 Attenuated mycobacterium tuberculosis vaccines |
| 08/28/2003 | WO2003069997A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins |
| 08/28/2003 | WO2003055911A3 Cystine-knot fold protein |
| 08/28/2003 | WO2003043986A8 Polypeptides of moraxella (branhamella) catarrhalis |